NEW YORK, July 22, 2015 /PRNewswire/ -- Attorney
Advertising -- Bronstein, Gewirtz & Grossman, LLC is
investigating potential claims on behalf of purchasers of the
securities of XOMA Corporation. ("XOMA" or the "Company")
(NasdaqGM: XOMA -News). Such investors are advised to contact
Peretz Bronstein or his investor
relations coordinator Eitan Kimelman
at info@bgandg.com or 212-697-6484.
The investigation concerns whether XOMA and certain of its
officers and/or directors have violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934.
On July 22, 2015, pre-market, the
Company announced that a Phase III trial of its treatment
(gevokizumab) for Behcet's disease in the eye missed the primary
endpoint of time to first acute ocular exacerbation. The company
announced that it will continue to work with its French partner,
Servier, to conduct a thorough analysis of the data.
Following this news, shares of XOMA fell $3.265 per share or 74.29% during intraday
trading to trade at $1.13 on
July 22, 2015.
If you are aware of any facts relating to this investigation, or
purchased shares of XOMA, you can assist this investigation by
contacting Peretz Bronstein or his
Investor Relations Coordinator Eitan
Kimelman of Bronstein, Gewirtz & Grossman, LLC at
212-697-6484 or via email info@bgandg.com. Those who inquire
by e-mail are encouraged to include their mailing address, email
and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-xoma-corporation-300117164.html
SOURCE Bronstein, Gewirtz & Grossman, LLC